| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.988 | 163 | 0 | 1997 | 2020 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
group | 0.400 | None | 0.992 | 129 | 0 | 1983 | 2020 | ||||||||
|
serine/threonine kinase 11 | 0.435 | 0.808 | 0.99 |
|
group | 0.400 | None | 0.968 | 124 | 1 | 1998 | 2019 | ||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.975 | 122 | 5 | 1992 | 2020 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
group | 0.400 | None | 0.966 | 116 | 1 | 1995 | 2019 | ||||||||
|
vitamin D receptor | 0.352 | 0.885 | 1.7E-05 |
|
group | 0.400 | None | 0.956 | 113 | 2 | 1996 | 2019 | ||||||||
|
kinase insert domain receptor | 0.378 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.982 | 112 | 2 | 2001 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
group | 0.400 | None | 0.945 | 110 | 14 | 1992 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
group | 0.400 | None | 0.972 | 108 | 3 | 1992 | 2020 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 0.400 | None | 0.941 | 102 | 3 | 1996 | 2019 | ||||||||
|
glutathione S-transferase theta 1 | 0.393 | 0.923 | 1.5E-04 |
|
group | 0.400 | None | 0.915 | 94 | 0 | 1996 | 2019 | ||||||||
|
BRCA1 associated protein 1 | 0.454 | 0.731 | 0.99 |
|
group | 0.400 | None | 1.000 | 91 | 1 | 2011 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.400 | None | 0.955 | 89 | 8 | 1983 | 2019 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.943 | 87 | 0 | 1999 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
group | 0.400 | None | 0.977 | 86 | 0 | 1992 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
group | 0.400 | None | 0.976 | 82 | 2 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
group | 0.400 | None | 0.987 | 77 | 4 | 1994 | 2019 | ||||||||
|
NAD(P)H quinone dehydrogenase 1 | 0.434 | 0.885 | 1.2E-09 |
|
group | 0.400 | None | 0.985 | 65 | 3 | 1993 | 2020 | ||||||||
|
fatty acid synthase | 0.474 | 0.846 | 1.00 |
|
group | 0.400 | None | 0.969 | 65 | 0 | 1999 | 2020 | ||||||||
|
E2F transcription factor 1 | 0.441 | 0.846 | 0.99 |
|
group | 0.400 | None | 0.952 | 63 | 1 | 1996 | 2019 | ||||||||
|
fibroblast growth factor receptor 1 | 0.362 | 0.885 | 1.00 |
|
group | 0.400 | None | 0.984 | 63 | 4 | 1988 | 2020 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
group | 0.400 | None | 0.952 | 62 | 1 | 1991 | 2020 | ||||||||
|
heat shock transcription factor 1 | 0.507 | 0.769 | 0.75 |
|
group | 0.400 | None | 0.968 | 62 | 0 | 1988 | 2020 | ||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
group | 0.400 | None | 1.000 | 59 | 5 | 1988 | 2020 | ||||||||
|
S-phase kinase associated protein 2 | 0.492 | 0.808 | 0.96 |
|
group | 0.400 | None | 0.983 | 58 | 0 | 2001 | 2020 |